AU2002241162A1 - Intimins in the prevention or treatment of infections:ii - Google Patents

Intimins in the prevention or treatment of infections:ii

Info

Publication number
AU2002241162A1
AU2002241162A1 AU2002241162A AU2002241162A AU2002241162A1 AU 2002241162 A1 AU2002241162 A1 AU 2002241162A1 AU 2002241162 A AU2002241162 A AU 2002241162A AU 2002241162 A AU2002241162 A AU 2002241162A AU 2002241162 A1 AU2002241162 A1 AU 2002241162A1
Authority
AU
Australia
Prior art keywords
intimins
infections
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002241162A
Other languages
English (en)
Inventor
Gordon Dougan
Gadi Frankel
Steve Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0107837A external-priority patent/GB0107837D0/en
Priority claimed from GB0107840A external-priority patent/GB0107840D0/en
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2002241162A1 publication Critical patent/AU2002241162A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
AU2002241162A 2001-03-29 2002-03-26 Intimins in the prevention or treatment of infections:ii Abandoned AU2002241162A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0107837A GB0107837D0 (en) 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:II
GB0107840.1 2001-03-29
GB0107840A GB0107840D0 (en) 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:I
GB0107837.7 2001-03-29
PCT/GB2002/001462 WO2002079247A2 (en) 2001-03-29 2002-03-26 Intimins in the prevention or treatment of infections:ii

Publications (1)

Publication Number Publication Date
AU2002241162A1 true AU2002241162A1 (en) 2002-10-15

Family

ID=26245909

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002251202A Abandoned AU2002251202A1 (en) 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i
AU2002241162A Abandoned AU2002241162A1 (en) 2001-03-29 2002-03-26 Intimins in the prevention or treatment of infections:ii

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2002251202A Abandoned AU2002251202A1 (en) 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i

Country Status (3)

Country Link
EP (1) EP1372709A2 (de)
AU (2) AU2002251202A1 (de)
WO (2) WO2002079240A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305525C (zh) * 2004-03-27 2007-03-21 中国人民解放军第三军医大学 人和易感动物o157菌基因工程多价亚单位疫苗及制备方法
GB2473523A (en) * 2009-09-10 2011-03-16 Solus Scient Solutions Ltd Nalidixic acid and lithium in a base medium for the culture of Listeria
CN103212060B (zh) * 2013-04-23 2014-11-05 中国人民解放军军事医学科学院微生物流行病研究所 蛋白及其组合物与在制备预防、诊断或治疗ehec感染产品中的应用
CN105821065A (zh) * 2016-04-29 2016-08-03 南方医科大学 一种双抗原重组蛋白及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0937148A1 (de) * 1996-04-19 1999-08-25 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidin-markieres intimin und verfahren zur verwendung von intimin zur anregungeiner immunantwort und als antigenträger mit targeting-fähigkeit
JP2000510332A (ja) * 1996-04-19 2000-08-15 ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン インチミンを単独で、または１以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
GB9803322D0 (en) * 1998-02-16 1998-04-15 Imperial College Methods
GB9901897D0 (en) * 1999-01-29 1999-03-17 Imp College Innovations Ltd Biological material and use thereof
JP2004516333A (ja) * 2001-01-04 2004-06-03 ユニバーシティー オブ サスカチェワン 腸管出血性大腸菌ワクチン

Also Published As

Publication number Publication date
AU2002251202A1 (en) 2002-10-15
WO2002079247A2 (en) 2002-10-10
WO2002079247A3 (en) 2003-10-30
WO2002079240A3 (en) 2003-06-26
WO2002079240A2 (en) 2002-10-10
EP1372709A2 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
GB0125222D0 (en) Composition for the treatment of microbial infections
WO2003088897A3 (en) Fab i inhibitors
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001260834A1 (en) The treatment of herpes
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2002319286A1 (en) Skin treatment
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002327100A1 (en) Member excellent in antibacterial and/or antialgae effects and process for producing the same
AU2002310922A1 (en) Interferons in the treatment of ischemia
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001258675A1 (en) Treating infections
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
AU2335601A (en) Treatment or prevention of diarrhea
AU2002344855A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
AUPR814901A0 (en) Water treatment
AU2002324798A1 (en) Pyrazolo-pyridines for the treatment of herpes infections
AU2002251847A1 (en) Vaccine and compositions for the prevention and treatment of neisserial infections
AU2001281747A1 (en) Composition and method for the treatment or prevention of hiv infection
AU2002357468A1 (en) Use of 2-acylindoles in the treatment of tumors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase